Pmv Non Current Liabilities Total vs Total Assets Analysis

PMVP Stock  USD 1.39  0.03  2.11%   
Pmv Pharmaceuticals financial indicator trend analysis is much more than just breaking down Pmv Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pmv Pharmaceuticals is a good investment. Please check the relationship between Pmv Pharmaceuticals Non Current Liabilities Total and its Total Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Pmv Stock, please use our How to Invest in Pmv Pharmaceuticals guide.

Non Current Liabilities Total vs Total Assets

Non Current Liabilities Total vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pmv Pharmaceuticals Non Current Liabilities Total account and Total Assets. At this time, the significance of the direction appears to have pay attention.
The correlation between Pmv Pharmaceuticals' Non Current Liabilities Total and Total Assets is -0.92. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Assets in the same time period over historical financial statements of Pmv Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Pmv Pharmaceuticals' Non Current Liabilities Total and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Pmv Pharmaceuticals are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Non Current Liabilities Total i.e., Pmv Pharmaceuticals' Non Current Liabilities Total and Total Assets go up and down completely randomly.

Correlation Coefficient

-0.92
Relationship DirectionNegative 
Relationship StrengthSignificant

Non Current Liabilities Total

Total Assets

Total assets refers to the total amount of Pmv Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Pmv Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Pmv Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pmv Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Pmv Stock, please use our How to Invest in Pmv Pharmaceuticals guide.At this time, Pmv Pharmaceuticals' Tax Provision is relatively stable compared to the past year. As of 02/17/2025, Issuance Of Capital Stock is likely to grow to about 52.1 M, while Selling General Administrative is likely to drop slightly above 17.1 M.
 2022 2023 2024 2025 (projected)
Interest Income3.6M9.8M11.3M11.8M
Net Interest Income3.6M9.8M11.3M11.8M

Pmv Pharmaceuticals fundamental ratios Correlations

0.860.850.990.850.990.71-0.63-0.780.770.680.690.43-0.330.990.880.63-0.920.970.95-0.910.990.690.990.920.99
0.860.990.870.890.880.89-0.25-0.940.90.250.890.37-0.580.790.920.87-0.860.840.96-0.830.870.890.790.920.77
0.850.990.850.910.860.9-0.19-0.940.940.230.90.42-0.560.780.940.88-0.830.830.95-0.80.850.90.780.920.76
0.990.870.850.811.00.72-0.66-0.780.730.670.690.44-0.320.980.850.64-0.950.980.96-0.951.00.70.980.920.98
0.850.890.910.810.820.78-0.2-0.840.930.370.790.39-0.520.810.990.75-0.710.830.88-0.680.810.790.810.870.8
0.990.880.861.00.820.72-0.65-0.790.740.650.70.42-0.340.970.860.65-0.950.970.97-0.951.00.710.970.920.97
0.710.890.90.720.780.72-0.01-0.970.85-0.010.960.61-0.580.630.830.98-0.790.730.84-0.760.721.00.640.910.62
-0.63-0.25-0.19-0.66-0.2-0.65-0.010.09-0.01-0.90.02-0.12-0.2-0.69-0.220.10.61-0.62-0.470.64-0.660.02-0.69-0.37-0.71
-0.78-0.94-0.94-0.78-0.84-0.79-0.970.09-0.88-0.11-0.95-0.490.65-0.71-0.9-0.940.82-0.8-0.90.8-0.78-0.97-0.71-0.95-0.7
0.770.90.940.730.930.740.85-0.01-0.880.190.840.45-0.480.710.950.83-0.650.730.84-0.610.730.850.710.840.69
0.680.250.230.670.370.65-0.01-0.9-0.110.19-0.040.120.230.760.37-0.13-0.490.650.48-0.510.67-0.040.750.370.77
0.690.890.90.690.790.70.960.02-0.950.84-0.040.39-0.760.610.830.99-0.760.670.81-0.730.690.980.620.890.6
0.430.370.420.440.390.420.61-0.12-0.490.450.120.390.210.420.410.49-0.470.540.46-0.460.440.560.430.540.42
-0.33-0.58-0.56-0.32-0.52-0.34-0.58-0.20.65-0.480.23-0.760.21-0.26-0.55-0.680.41-0.29-0.460.39-0.32-0.65-0.26-0.55-0.24
0.990.790.780.980.810.970.63-0.69-0.710.710.760.610.42-0.260.840.55-0.890.960.91-0.890.980.621.00.881.0
0.880.920.940.850.990.860.83-0.22-0.90.950.370.830.41-0.550.840.79-0.770.870.92-0.740.850.830.840.920.83
0.630.870.880.640.750.650.980.1-0.940.83-0.130.990.49-0.680.550.79-0.730.630.78-0.690.640.990.560.860.53
-0.92-0.86-0.83-0.95-0.71-0.95-0.790.610.82-0.65-0.49-0.76-0.470.41-0.89-0.77-0.73-0.93-0.941.0-0.95-0.78-0.89-0.94-0.89
0.970.840.830.980.830.970.73-0.62-0.80.730.650.670.54-0.290.960.870.63-0.930.95-0.920.980.710.960.930.96
0.950.960.950.960.880.970.84-0.47-0.90.840.480.810.46-0.460.910.920.78-0.940.95-0.920.960.830.920.960.9
-0.91-0.83-0.8-0.95-0.68-0.95-0.760.640.8-0.61-0.51-0.73-0.460.39-0.89-0.74-0.691.0-0.92-0.92-0.95-0.75-0.89-0.92-0.88
0.990.870.851.00.811.00.72-0.66-0.780.730.670.690.44-0.320.980.850.64-0.950.980.96-0.950.70.980.920.98
0.690.890.90.70.790.711.00.02-0.970.85-0.040.980.56-0.650.620.830.99-0.780.710.83-0.750.70.620.910.6
0.990.790.780.980.810.970.64-0.69-0.710.710.750.620.43-0.261.00.840.56-0.890.960.92-0.890.980.620.881.0
0.920.920.920.920.870.920.91-0.37-0.950.840.370.890.54-0.550.880.920.86-0.940.930.96-0.920.920.910.880.87
0.990.770.760.980.80.970.62-0.71-0.70.690.770.60.42-0.241.00.830.53-0.890.960.9-0.880.980.61.00.87
Click cells to compare fundamentals

Pmv Pharmaceuticals Account Relationship Matchups

Pmv Pharmaceuticals fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets365.5M331.6M270.3M252.2M290.0M254.1M
Other Current Liab4.8M8.2M6.8M9.9M11.4M6.0M
Total Current Liabilities6.4M12.2M10.8M14.0M16.1M9.2M
Total Stockholder Equity359.1M308.6M246.0M225.7M259.5M187.5M
Net Tangible Assets(70.5M)359.1M308.6M246.0M282.9M175.4M
Property Plant And Equipment Net569K13.2M20.5M19.0M21.9M23.0M
Net Debt(361.4M)(161.3M)(94.3M)(24.4M)(22.0M)(23.1M)
Retained Earnings(109.9M)(167.7M)(241.0M)(310.0M)(279.0M)(265.1M)
Accounts Payable1.6M3.2M3.0M3.2M3.7M2.7M
Cash361.4M172.5M108.3M37.7M33.9M32.2M
Non Current Assets Total770K30.3M23.3M44.7M51.5M54.0M
Cash And Short Term Investments361.4M297.2M241.1M203.1M233.5M232.1M
Common Stock Shares Outstanding44.8M45.1M45.6M48.0M55.2M47.3M
Short Term Investments0.0124.7M132.8M165.4M190.2M199.7M
Liabilities And Stockholders Equity365.5M331.6M270.3M252.2M290.0M254.1M
Non Current Liabilities Total1.6M10.8M13.4M12.4M11.2M10.6M
Other Current Assets6.7M4.1M6.0M4.4M5.0M4.0M
Other Stockholder Equity469.0M476.4M487.5M535.5M615.8M362.5M
Total Liab6.4M23.0M24.3M26.5M23.8M22.6M
Net Invested Capital359.1M308.6M246.0M225.7M259.5M187.5M
Property Plant And Equipment Gross569K13.2M20.5M22.3M25.7M26.9M
Total Current Assets364.8M301.3M247.0M207.4M238.5M235.5M
Net Working Capital358.4M289.1M236.2M193.4M222.4M226.3M
Property Plant Equipment739K569K13.2M11.0M12.6M13.2M

Additional Tools for Pmv Stock Analysis

When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.